Regulatory11 Apr 2026, 12:30 pm
Medplus Subsidiary's Odisha Store Drug License Suspended; ₹3.8 Lacs Loss
AI Summary
Medplus Health Services Ltd announced that its subsidiary, Optival Health Solutions Private Limited, has received a five-day suspension order for a drug license. The order, issued by the Dy. Drugs Controller, Southern Zone, Berhampur, Odisha, on April 10, 2026, affects one store in Odisha. The violation is cited under Rule 65 of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945. This regulatory action is expected to result in a potential revenue loss of ₹3.80 lacs for the company.
Key Highlights
- Medplus subsidiary's Odisha store drug license suspended for 5 days.
- Suspension by Dy. Drugs Controller, Odisha, effective April 10, 2026.
- Violation under Drugs and Cosmetics Act, 1940, and Rules, 1945.
- Estimated potential revenue loss of ₹3.80 lacs.